Purchase this article with an account.
I. Behlau, M. Butler, M. Cummings, J.-A. Graziano, C. Kurtz, E. Lowell, D. Rich, C. Weeks, C. McLellan; Evaluating the Safety of the Current Practice of Ophthalmic Solution Usage in an Academic Eye Specialty Hospital. Invest. Ophthalmol. Vis. Sci. 2007;48(13):750.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The Collaborative Eye Research Group (CERG) was formed to evaluate existing Massachusetts Eye and Ear Infirmary (MEEI) ophthalmic solution administration procedures. This research project was designed to provide supportive evidence that the current policies and procedures in practice at the MEEI for ophthalmic solution usage are safe.
A sampling of the most commonly used ophthalmic solutions prepared by both the MEEI hospital pharmacy and from commercially available sources was tested for potential contamination. Six different patient care areas were examined. Variables analyzed included: 1) ophthalmic solutions with and without preservatives, 2) MEEI prepared and commercially available solutions, 3) multiple user versus single user solutions, 4) duration of use, and 5) different storage conditions (temperature, time of storage, container composition).
All the solutions from the locations and varying conditions studied were found to be free of contamination. Therefore, it can be concluded that the current MEEI policies and procedures for administration are safe, while also being a cost-effective practice.
Our surveillance study validates current policies and procedures in place at the MEEI. CERG recognizes that any deviation or breaks from these safe practices may result in adverse outcomes. This underscores the need for regular surveillance of current practices and any modifications to those practices.
This PDF is available to Subscribers Only